CC, W., AS, L., SH, L., KC, C., MY, S., & CT, C. (2019). Spironolactone ameliorates endothelial dysfunction through inhibition of the AGE/RAGE axis in a chronic renal failure rat model. BMC nephrology, 20(1), 351. https://doi.org/10.1186/s12882-019-1534-4
Chicago Style (17th ed.) CitationCC, Wang, Lee AS, Liu SH, Chang KC, Shen MY, and Chang CT. "Spironolactone Ameliorates Endothelial Dysfunction Through Inhibition of the AGE/RAGE Axis in a Chronic Renal Failure Rat Model." BMC Nephrology 20, no. 1 (2019): 351. https://doi.org/10.1186/s12882-019-1534-4.
MLA (9th ed.) CitationCC, Wang, et al. "Spironolactone Ameliorates Endothelial Dysfunction Through Inhibition of the AGE/RAGE Axis in a Chronic Renal Failure Rat Model." BMC Nephrology, vol. 20, no. 1, 2019, p. 351, https://doi.org/10.1186/s12882-019-1534-4.